APREPITANT RMB aprepitant 125 mg capsule blister pack
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
29-07-2019
अनुरोध भेजा।
सक्रिय संघटक:
aprepitant, Quantity: 125 mg
थमां उपलब्ध:
Southern Cross Pharma Pty Ltd
फार्मास्यूटिकल फॉर्म:
Capsule, hard
रचना:
Excipient Ingredients: microcrystalline cellulose; sodium lauryl sulfate; Gelatin; titanium dioxide; hypromellose; sucrose; iron oxide red; poloxamer; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; Shellac; sulfuric acid
प्रशासन का मार्ग:
Oral
पैकेज में यूनिट:
1
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
Aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,Aprepitant is indicated for the prevention of postoperative nausea and vomiting.
उत्पाद समीक्षा:
Visual Identification: opaque hard gelatin capsules with a pink cap and white body, printed with 125mg on the body; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
प्राधिकरण का दर्जा:
Registered
प्राधिकरण की तारीख:
2019-07-03
